Hi everyone! We are Daniel, Felix, and Samuel, and we are building Cellbyte.

TL;DR: Cellbyte’s AI agents help pharma companies launch new drugs worldwide. Market-leading firms are using Cellbyte to answer questions like “What price can we achieve for our new drug in the U.S. versus Germany?“.

Problem:

Most medicines being launched are missing their revenue potential by a large margin due to messy pharma data causing expensive inefficiencies. When preparing a drug launch, pharmaceutical manufacturers have to choose between three options:

• Manual research: time-consuming, human errors, language barriers
• Databases: $300k / year, poor data quality, limited scope
• Consulting: $300k / project, answers in weeks, data snapshots

Solution:

• Cellbyte consists of 3 main layers:
  • High-quality data: comprehensive, globally interconnected, up-to-date
  • Analytics: instant due to integrated databases, personalized to each user
  • Workflows: built on deep user understanding, human-in-the-loop-interactions, consulting-level outputs
• Cellbyte’s AI workforce replaces Legacy Providers
• We’re live in 12 key markets, adding new ones every week

Who we are:

The three co-founders have known and worked with each other for many years: Daniel brings 5+ years of industry experience from his previous job at leading global Life Sciences consultancy Simon-Kucher. Felix has sold $3m+ ACV enterprise deals to customers like H&M for his previous YC startup. Samuel holds an MSc in Information Systems from TUM, and has built enterprise AI applications from scratch as ML Engineer at Celonis.

Asks:

• June 2025 - We are fundraising! Get in touch with Felix (felix.steinbrenner@cellbyte.com) if you are an investor or happen to know someone who might be a good fit.